Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesPinealon's Cognitive Promise: Unpacking the 2026 Evidence
A deep dive into Pinealon, focusing on the latest 2026 clinical evidence and its implications for cognitive health and resilience.
PeptidesPinealon: Cognitive Resilience Updates &
Dive into the latest 2025-2026 clinical research on Pinealon, focusing on its role in cognitive resilience and updated recommendations for brain health.
PeptidesPinealon: Cognitive Resilience Breakthroughs by
New research into Pinealon's effects on cognitive resilience, antioxidant defences, and neuronal gene expression, specifically clinical evidence from 2025-2026.
PeptidesDihexa After 50: Reclaiming Cognitive Edge in
Dihexa, a potent hexapeptide derivative, offers intriguing prospects for cognitive support in adults over 50, targeting age-related declines in neuroplasticity. We examine its mechanisms, preclinical evidence, and considerations for its use.
PeptidesPinealon 2026: The Latest Evidence for
Dive into the newest 2025-2026 clinical evidence on Pinealon, examining its role in enhancing cognitive resilience and its implications for brain health.
PeptidesPinealon: Latest Cognitive Resilience Evidence
New evidence for 2026 clarifies Pinealon's role in cognitive resilience. We review the latest trials, updated mechanisms, and refined recommendations for this bioregulator.
PeptidesDihexa Side Effects & Safety: What to Know
A deep dive into Dihexa's safety profile, discussing documented side effects, interactions, and contraindications from preclinical research.
PeptidesDihexa for Women: Cognitive Enhancement in 2026
A deep dive into Dihexa's implications for women's cognitive function, exploring its mechanisms, benefits, and crucial physiological considerations.
PeptidesDihexa in 2026: Unpacking the Latest Clinical
New clinical data on Dihexa, a hexapeptide for cognitive function, reveals nuanced efficacy. We analyse the 2025-2026 evidence.
PeptidesDihexa: Latest 2026 Evidence and Cognitive
Dihexa, a potent hexapeptide, continues to intrigue researchers. This article examines the latest 2026 evidence surrounding its cognitive enhancement potential and safety profile.
PeptidesDihexa and Longevity Biomarkers: What to Expect
Could Dihexa, a potent hexapeptide, influence key longevity biomarkers? We examine the current preclinical evidence.
PeptidesCJC-1295 for Enhanced Cognition & Focus in
CJC-1295, a GHRH analogue, is gaining traction for its potential cognitive benefits. We delve into the science of its impact on focus, memory, and neuroplasticity.
PeptidesPinealon's Sleep & Circadian Impact:
Investigating Pinealon's potential to optimise sleep and circadian rhythms, this expert analysis unpacks its mechanisms, benefits, and risks for healthspan in 2026.
PeptidesDihexa UK Availability & Sourcing: What to
Understanding Dihexa's legal standing and sourcing landscape in the UK is crucial for anyone considering its potential cognitive benefits.
PeptidesPinealon Stacking: Brain Boost Synergies in
Exploring Pinealon's potential when combined with other compounds for enhanced cognitive function and neuroprotection. Practical stacking strategies for optimal results.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.